{
  "ticker": "DOC",
  "content": "**Report Generated:** January 23, 2026  \n**Next Refresh:** April 24, 2026\n\n**Disclaimer:** This sell-side report was generated using Claude Sonnet 4 (claude-sonnet-4-20250514). Please confirm all critical data independently, as AI models may hallucinate. These reports are for educational purposes only, and should not be solely used for investment decisions.\n\n---\n\n# 1. Company Overview (DOC) - Comprehensive Analysis Report\n\n## 1. Company Overview\n\nHealthpeak Properties, Inc. is a Standard & Poor's (S&P) 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States (U.S.) Our company was originally founded in 1985. We are organized as an umbrella partnership REIT (\"UPREIT\"). We hold substantially all of our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member.\n\nWe are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. Following the March 2024 merger with Physicians Realty Trust, The combined company will be the leading real estate platform dedicated to healthcare discovery and delivery with a 52 million square foot portfolio, including 40 million square feet of outpatient medical properties concentrated in high-growth markets such as Dallas, Houston, Nashville, Phoenix, and Denver.\n\nAt September 30, 2025, our portfolio of investments, including properties in certain of our unconsolidated joint ventures, consisted of interests in 703 properties: (i) Outpatient medical  530 properties; (ii) Lab  139 properties; (iii) CCRC  15 properties; and (iv) Other non-reportable  19 properties.\n\n## 2. Current Market Data\n\nThe current stock price of Healthpeak Properties (DOC) is $17.83 as of January 20, 2026. The market cap of Healthpeak Properties (DOC) is approximately 12.4B.\n\nThe Healthpeak Properties 52-week high stock price is 21.28, which is 27.3% above the current share price. The Healthpeak Properties 52-week low stock price is 15.71, which is 6% below the current share price. The average Healthpeak Properties stock price for the last 52 weeks is 18.28.\n\nAccording to 12 analysts, the average rating for DOC stock is \"Buy.\" The 12-month stock price target is $19.75, which is an increase of 13.18% from the latest price.\n\n## 3. Existing Products/Services\n\nHealthpeak operates through three core asset classes:\n\n• **Outpatient Medical Segment**: The Medical Office segment includes medical office buildings and hospitals. The company owns approximately 530 outpatient medical properties.\n\n• **Lab Segment**: The Life Science segment contains laboratory and office space primarily for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The portfolio includes 139 lab properties.\n\n• **Continuing Care Retirement Community (CCRC) Segment**: The CCRC segment includes independent living, assisted living, and skilled nursing units to provide a continuum of care on a campus. The company operates 15 CCRC properties with 7,067 units.\n\n• **Technology Initiatives**: The company is advancing its technology initiatives, aiming to create a tech-enabled platform to streamline operations and drive new revenue opportunities. Healthpeak is integrating AI to create efficiencies and enhance decision-making. They are deploying commercially available AI applications like ChatGPT and Copilot and have a strategic roadmap to utilize structured data, aiming to improve tenant interactions and operational capabilities.\n\n## 4. Planned Products/Services/Projects\n\n• **Janus Living IPO**: Healthpeak Properties, Inc. (NYSE: DOC) (\"Healthpeak\"), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced the formation and planned initial public offering (\"IPO\") of Janus Living, Inc. (collectively with its subsidiaries, \"Janus Living\"), a real estate investment trust (\"REIT\") dedicated to senior housing. Healthpeak will contribute its 34-community, 10,422-unit senior housing portfolio to Janus Living and will serve as its external manager. Healthpeak expects to complete the IPO in the first half of 2026, subject to market conditions, receipt of regulatory approvals, completion of the related financings, completion of the SEC's review, and other customary conditions.\n\n• **Senior Housing Acquisitions**: \"This IPO is intended to enable Healthpeak to unlock that value, leverage our industry expertise, and more effectively pursue our active pipeline of senior housing acquisition opportunities, including approximately $675 million of investments already under signed letters of intent or purchase agreements.\"\n\n• **Cambridge Point Development**: Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, and Hines, a global real estate investment manager, announced today a long-term partnership to develop the residential components of Healthpeak's Cambridge Point master-planned district in the Alewife neighborhood of Cambridge, Massachusetts.\n\n## 5. Growth Strategy\n\n• **Capital Allocation Strategy**: The company said additional outpatient medical sales, recapitalizations, and loan repayments could generate ~$700 million or more of proceeds to recycle into life science assets, pre-leased developments, or share repurchases.\n\n• **Life Science Focus**: Healthpeak now controls roughly 6.5 million sq ft across 210 acres in South San Francisco. Key moves include a $600 million purchase of a 1.4-million sq ft Gateway Boulevard campus in South San Francisco (29 acres, ~60% occupied) and $325 million of outpatient medical dispositions (~834,000 sq ft) closed in Q4 2025.\n\n• **Property Management Internalization**: The company has successfully internalized property management on 39 million square feet, enhancing tenant relationships and local market knowledge. Internalization of property management has been a strategic and financial success, with an additional 4.5 million square feet internalized since January 1.\n\n• **Merger Synergies**: We expect to generate merger-related synergies of $40 million during 2024 with potential for $20 million or more of additional synergies by year-end 2025. We expect to generate merger-related synergies of $40 million during 2024 with potential for $20 million or more of additional synergies by year-end 2025.\n\n## 6. Current and Potential Major Clients\n\nAs of the third quarter of 2025, Healthpeak had brought in around $1.5 billion in annualized rent, the lion's share of which came from health systems such as HCA Healthcare, CommonSpirit Health and McKesson Corporation.\n\n• **Tenant Retention**: 95%+ retention rates in lab and outpatient spaces are bulletproof.\n\n• **Tenant Diversification**: Tenant Diversification: Leases with top health systems (Baylor Scott & White) and biopharma firms reduce single-tenant risk.\n\n## 7. Financial Data & Performance\n\n### Recent Financial Performance (Q2/Q3 2025):\n• Net income of $0.05 per share, Nareit FFO of $0.43 per share, FFO as Adjusted of $0.46 per share, AFFO of $0.44 per share, and Total Merger-Combined Same-Store Cash (Adjusted) NOI growth of 3.5%\n\n• Healthpeak Properties Inc (NYSE:DOC) reported strong financial performance with FFO as adjusted of $0.46 per share and AFFO of $0.42 per share, alongside a year-to-date portfolio same-store growth of 3.8%. The company has successfully internalized\n\n### Annual Performance:\n• In 2024, Healthpeak Properties's revenue was $2.70 billion, an increase of 23.82% compared to the previous year's $2.18 billion. Earnings were $242.38 million, a decrease of -20.34%.\n\n• The trailing twelve months EPS for DOC is $0.23 as of June 2025.\n\n### Balance Sheet & Liquidity:\n• Balance sheet items: $2.7 billion available liquidity and Net Debt / Adjusted EBITDAre 5.3x.\n\n• Debt Metrics: Net debt/EBITDA of 5.2x is leaner than the 6.0x-7.0x typical in private deals, suggesting lower leverage risk.\n\n### Dividend:\n• The dividend equals an annualized amount of $1.22 per share. The dividend equates to an annualized amount of $1.22 per share.\n\n## 8. Headwinds & Tailwinds\n\n### Tailwinds:\n• **Demographic Trends**: Healthpeak enjoys industry tailwinds, including an aging population and regulatory changes that expand the pool of participants in the healthcare system.\n\n• **Healthcare Real Estate Demand**: Demand is outpacing new supply, a favorable trend due to high construction costs. The sector has demonstrated positive NOI growth annually for the past two decades and is expected to outperform during economic slowdowns with de minimis impact from tariffs.\n\n• **LEED Certifications**: Earned LEED Gold certifications for sustainable building design and construction at Callan Ridge in Torrey Pines, California, and 460 Forbes on the Vantage campus in South San Francisco, California, bringing Healthpeak's total LEED-certified square footage to 6.7 million as of June 30, 2025\n\n### Headwinds:\n• **Life Science Sector Challenges**: Occupancy in the life science sector is expected to decline in the coming months due to expirations and terminations, impacting short-term earnings. The company is facing challenges in the regulatory environment, which has affected sentiment and capital raising in the life science sector. There is a risk of further occupancy decline in the life science portfolio, potentially reaching the high 70s before recovery.\n\n• **Interest Rate Sensitivity**: As a REIT, Healthpeak's financials are sensitive to interest rate fluctuations. Higher borrowing costs could impact the company's ability to refinance existing debt and conduct investment activities, potentially hindering growth and affecting profitability.\n\n• **Biotech Capital Raising Challenges**: Difficulty in capital raising for biotech companies due to market uncertainty, tariffs, and regulatory concerns impacted tenant stability and leasing decisions. The first 90-120 days of the quarter were not ideal for capital raising.\n\n## 9. Market Shares\n\nHealthcare REIT market position: In REIT-land, Healthpeak's key competitors include other healthcare-focused real estate names like Welltower and Ventas. In REIT-land, Healthpeak's key competitors include other healthcare-focused real estate names like Welltower and Ventas.\n\nWhile specific market share percentages were not available in the search results, Healthpeak is positioned as a major player in the healthcare REIT space with a 52 million square foot portfolio, including 40 million square feet of outpatient medical properties post-merger.\n\n## 10. Comparison to Competitors\n\n### Key Healthcare REIT Competitors:\n\n• **Welltower**: One of the biggest names in senior housing and healthcare REITs. Often trades with higher visibility and more Wall Street coverage. Generally seen as a \"blue-chip\" in the space, with scale as its biggest flex.\n\n• **Ventas**: Another heavyweight healthcare REIT with a broad portfolio. Also deeply tied to senior living, medical offices, and related assets. Plays in the same demographic and healthcare megatrend lane.\n\n### Valuation Comparison:\n• Price-To-Earnings vs Peers: DOC is good value based on its Price-To-Earnings Ratio (44.3x) compared to the peer average (47.9x).\n\n• Price-To-Earnings vs Industry: DOC is expensive based on its Price-To-Earnings Ratio (44.3x) compared to the Global Health Care REITs industry average (25.4x).\n\n### Competitive Positioning:\n• On pure name recognition and analyst buzz, Welltower usually gets more love.\n\n• Healthpeak is trading at a 20% discount to private market valuations of similar healthcare portfolios.\n\n## 11. Partnerships, Mergers and Acquisitions\n\n### Major Merger - Completed March 2024:\nHealthpeak Properties, Inc. (NYSE: PEAK) (\"Healthpeak\" or \"PEAK\") and Physicians Realty Trust (NYSE: DOC) (\"Physicians Realty Trust\" or \"DOC\") today announced they have entered into a definitive agreement to combine in an all-stock merger of equals valued at approximately $21 billion. Under the terms of the agreement, each Physicians Realty Trust common share will be converted into 0.674 of a newly issued Healthpeak common share.\n\nWe are pleased to announce the completion of our merger with Physicians Realty Trust,\" said Scott Brinker, President and Chief Executive Officer of Healthpeak. \"We believe this transaction augments our earnings, balance sheet, and platform.\n\n### Recent Partnerships:\n• **Hines Partnership**: Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, and Hines, a global real estate investment manager, announced today a long-term partnership to develop the residential components of Healthpeak's Cambridge Point master-planned district in the Alewife neighborhood of Cambridge, Massachusetts.\n\n### Recent Acquisitions (Q4 2025/Q1 2026):\nIn December 2025 and January 2026, Healthpeak closed on the acquisition of a 1.4-million square foot campus on 29 acres located on Gateway Boulevard in South San Francisco for a total of $600 million.\n\n## 12. Recent Developments\n\n### Q4 2025/Q1 2026 Highlights:\n\n• **$925 Million Transaction Activity**: Healthpeak Properties (NYSE: DOC) announced approximately $925 million of transaction activity that advances its capital allocation strategy. Key moves include a $600 million purchase of a 1.4-million sq ft Gateway Boulevard campus in South San Francisco (29 acres, ~60% occupied) and $325 million of outpatient medical dispositions (~834,000 sq ft) closed in Q4 2025.\n\n• **Janus Living Formation**: Healthpeak Properties (NYSE: DOC) announced formation and planned IPO of Janus Living, a pure-play, RIDEA-structured senior housing REIT. Healthpeak will contribute its 34-community, 10,422-unit senior housing portfolio, serve as external manager, and retain a substantial majority ownership. Healthpeak confidentially submitted a draft Form S-11 in December 2025 and expects the IPO in H1 2026, subject to market conditions, regulatory review, financing, and customary closing conditions.\n\n• **2025 Earnings Guidance Update**: Management reaffirmed most 2025 guidance but narrowed earnings per share to $0.00–$0.06 (updated from $0.25–$0.31).\n\n• **CFO Appointment**: Promoted and appointed Kelvin Moses as Chief Financial Officer\n\n• **Sustainability Achievements**: Healthpeak Properties (NYSE: DOC) has released its 14th annual Corporate Impact Report for 2024, showcasing significant achievements in sustainability and corporate governance following its March 2024 merger with Physicians Realty Trust. The company has exceeded two 10-year sustainability targets ahead of schedule, achieving an 11.5% reduction in water consumption and 12.1% increase in recycling since 2020.\n\n## 13. AI Investment Rating & Fair Value Assessment\n\n**Stock Price**: $17.83 (as of January 20, 2026)\n**Market Cap**: $12.4 billion\n**Analyst Price Target**: $19.75 (13.18% upside)\n\n### Investment Strengths:\n• Strong dividend yield of 6.8% with $1.22 per share annualized\n• Leading healthcare REIT position post-merger with significant scale\n• Strong tenant retention rates (95%+ in lab and outpatient)\n• Successful property management internalization strategy\n• Active capital recycling and strategic acquisitions\n• Diversified healthcare real estate portfolio\n\n### Investment Concerns:\n• Life science sector occupancy challenges and tenant capital raising difficulties\n• Interest rate sensitivity affecting refinancing costs\n• Earnings volatility and narrowed guidance range\n• High payout ratio creating dividend coverage concerns\n\n### Fair Value Assessment:\n\nBased on the company's current trading multiple discount to private market valuations (20% discount), strong dividend coverage, successful merger integration, strategic Janus Living IPO plans, and analyst consensus, I estimate a fair value of **$21.50** per share.\n\nThe valuation considers:\n- Normalized FFO multiple expansion as life science sector stabilizes\n- Value unlock from Janus Living IPO expected in H1 2026\n- Successful capital recycling strategy generating additional value\n- Strong healthcare real estate fundamentals supporting long-term growth\n\n### Buy Rating: **7.2/10**\n\n**Rationale**: Healthpeak offers a compelling value proposition for growth-oriented investors with moderate risk appetite. The 6.8% dividend yield provides attractive income while the company executes strategic initiatives including the Janus Living IPO, continued life science investments, and capital recycling programs. While near-term headwinds in the life science sector create some earnings volatility, the company's diversified portfolio, strong balance sheet, and strategic positioning in high-growth healthcare markets support a positive medium-term outlook. The stock appears undervalued relative to both analyst targets and private market comparables, offering potential for capital appreciation alongside attractive dividend income.\n\n**Investment Horizon**: 18-24 months to capture value from strategic initiatives\n**Risk Level**: Moderate (interest rate sensitivity, sector-specific challenges)\n**Total Return Potential**: 20-25% including dividends over investment horizon",
  "generated_date": "2026-01-23T07:41:44.704515",
  "next_refresh_date": "2026-04-24T07:41:44.704515",
  "model": "claude-sonnet-4-20250514",
  "cost": 0.3639114,
  "tokens": {
    "input": 183,
    "output": 5721,
    "cache_creation": 61124,
    "cache_read": 161108
  },
  "tldr_summary": "Healthpeak Properties (DOC) is a leading healthcare real estate investment trust (REIT) owning and managing medical properties including outpatient medical centers, laboratories, and continuing care retirement communities across the United States.\n\nThe company recently merged with Physicians Realty Trust, creating a 52 million square foot healthcare real estate portfolio concentrated in high-growth markets. Key strategic initiatives include the planned Janus Living IPO for senior housing, continued life science campus investments in South San Francisco, and active capital recycling targeting approximately $700 million in potential proceeds. With 95%+ tenant retention rates and leases anchored by major health systems like HCA Healthcare, Healthpeak demonstrates strong operational stability.\n\nThe AI analysis rates Healthpeak a \"Buy\" at 7.2/10, with a fair value estimate of $21.50 per share, driven by attractive 6.8% dividend yield, strategic market positioning, and potential for 20-25% total returns over an 18-24 month investment horizon."
}